Mettler-Toledo International Inc. to Host Second Quarter 2025 Earnings Conference Call
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250708770804/en/
Contacts
Adam UhlmanHead of Investor RelationsMETTLER TOLEDODirect: 614-438-4794adam.uhlman@mt.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
UBS Lowered its Price Target Berkshire Hathaway (BRK-B), Kept a Buy Rating
Berkshire Hathaway Inc. (NYSE:BRK-B) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On June 3, analyst Brian Meredith from UBS lowered its price target on Berkshire Hathaway Inc. (NYSE:BRK-B) from $606 to $591, while keeping a Buy rating on the stock. The analyst noted that the price revision reflects the conservative investment approach of Berkshire Hathaway Inc. (NYSE:BRK-B). The company's investment approach prioritizes liquidity and risk mitigation amidst volatile market conditions. However, while the analyst lowered the price target, he maintained a Buy rating due to the company's strong balance sheet and diversified investment portfolio. Brian Meredith noted that these factors are key strengths of Berkshire Hathaway Inc. (NYSE:BRK-B), which supports its long-term value. Skyscrapers with background of graphs and arrows Moreover, Qualivian Investment Partners also mentioned Berkshire Hathaway Inc. (NYSE:BRK-B) in its Q1 2025 investor letter. The fund noted the company to be among the top three contributors for the quarter. Berkshire Hathaway Inc. (NYSE:BRK-B) is a large holding company that owns and operates various businesses through its subsidiaries. While we acknowledge the potential of BRK-B as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
Companies Like Pfizer Inc (PFE) are Boosting the Cannabis Light Market
Pfizer Inc. (NYSE:PFE) is one of the . On July 1, GlobalNewswire reported that the Cannabis Light Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.6% from 2025 to 2030. This is because companies like Pfizer Inc. (NYSE:PFE) have entered the industry. In 2021, Pfizer Inc. (NYSE:PFE) entered the medical cannabis sector by acquiring Arena Pharmaceuticals for $6.7 billion. The report highlighted that the industry is rapidly evolving due to increased legalization and cultivation activities around the globe. This has led to key pharmaceutical companies like Pfizer Inc. (NYSE:PFE) to forge partnerships to maximize the efficient use of cannabis using advanced lighting techniques. A medical technician wearing protective gloves and a mask mixing a biopharmaceutical solution. Pfizer Inc. (NYSE:PFE) is an international biopharmaceutical company that researches, develops, manufactures, and sells medicines and vaccines. Its products cover a wide range of health areas, including oncology, primary care, and specialty care. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Clearwater Analytics Selected by Germany's Largest Public Insurer for Enhanced Investment Operations
Clearwater Analytics Holdings Inc. (NYSE:CWAN) is one of the most promising stocks according to Wall Street analysts. On July 2, Clearwater Analytics announced that Versicherungskammer Group selected Clearwater Analytics' cloud-based platform to enhance its middle, back-office, and risk functions for investment operations. The Versicherungskammer Group is the largest public insurer in Germany active in Bavaria, the Palatinate, Saarland, as well as in Berlin and Brandenburg. The decision to select Clearwater Analytics' cloud-based platform follows an operating model review initiated in 2024 and a subsequent rigorous selection process. A wide shot of a large financial data center. The partnership shifts Versicherungskammer's investment operations strategy and is central to its goal of future-proofing the company's investment capabilities. Additionally, the partnership allows the company to now focus on enhancing data quality, supporting decision-making processes, and improving risk and performance management. Clearwater Analytics Holdings Inc. (NYSE:CWAN) develops and provides a SaaS solution for automated investment data aggregation, reconciliation, accounting, and reporting services internationally. While we acknowledge the potential of CWAN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
